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medical history, presented with fever, followed by loss of ap-
petite, epigastric and right upper quadrant pain. She also 
complained of nausea and vomiting and 2-kg weight loss 
over one month period. She reported no change in bowel 
habit, no pruritus or icter. She lived in West Azarbaijan and 
denied any history of international travelling. Past history 
for asthma, allergy, allergic rhinitis was negative. Drug his-
tory  was  negative  except  for  H2-receptor  antagonist  and 
metochlopramide  which  she  took  during  last  month  for 
her recent gastrointestinal symptoms. Her vital signs were 
within normal range. The only physical finding was epigas-
tric tenderness. In initial assessment, she had a leukocytosis 
of 17,870/µL with 19.6% neutrophils, 18.8% lymphocytes, 56.1% 
eosinophils, and 1.2% basophils; she had a hemoglobin of 
12.4 mg/dL and a platelet count of 433,000/µL (Table 1). Liver 
function  tests  and  electrolytes  were  normal.  Erythrocyte 
sedimentation rate (ESR) was elevated up to 65 mm/h. C-re-
active protein (CRP) was 3+ positive. Urinalysis was normal. 
Stool  examination  for  ova/parasite  was  negative  in  three 
consecutive times. Serology tests for Fasciola, visceral larva 
migrans (Toxocara canis), and hydatid disease (Ecchinococ-
cus  granolosus)  were  negative.  An  abdominal  ultrasound 
revealed a hypoechoic liver mass with irregular borders and 
Background
The  hypereosinophilic  syndromes  (HES)  are  disorders 
marked by the sustained overproduction of eosinophils, of-
ten but not invariably, associated with damage to multiple 
organs due to eosinophilic infiltration and mediator release 
(1-4). The diagnosis of HES should be suspected in patients 
with sustained blood eosinophilia of ≥1500/µL, documented 
on at least two occasions, no other apparent etiologies for 
eosinophilia, and often signs and/or symptoms of end-or-
gan dysfunction. Hepatic involvement may take the form of 
chronic active hepatitis, focal hepatic lesions, eosinophilic 
cholangitis, or the Budd-Chiari syndrome. Manifestation of 
HES as liver mass is rare. Herein we report on two cases of 
HES presenting with liver mass.
Case 1
A 22-year-old Caucasian woman with unremarkable past 
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ABSTRACT ARTICLE INFO
Herein, we report on two cases of hypereosinophilic syndrome presenting as liver mass. 
One patient was a 22-year-old woman presented with fever, upper abdominal pain, nausea/
vomiting and a mass in the right liver lobe. The second patient was a 54-year-old man who 
presented with nausea and abdominal pain with significant weight loss. He had multiple 
lesions in both liver lobes. Both patients had eosinophilia that was not attributed to other 
causes such as allergy or parasites. The patients were treated with glucocorticosteroid and 
improved clinically. Imaging and laboratory abnormalities resolved.
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Figure 1. Note the mass lesion in the right liver lobe on abdominal CT performed with intravenous contrast
quadrant pain, not related to eating. He had nausea without 
vomiting. He reported 14-kg weight loss during this short pe-
riod. He lived in West Azarbaijan and denied history of inter-
national travelling. Past history for asthma, allergy and al-
lergic rhinitis was negative. Drug history was also negative. 
Physical  examination  was  insignificant  except  for  an  epi-
gastric tenderness in deep palpation. In initial assessment, 
he  had  leukocytosis  of  16,000/µL  (21.4%  neutrophils,  4.5% 
lymphocytes, 69% eosinophils, 1% basophils, and 3.3% mono-
cytes). He had a hemoglobin concentration of 10.4 mg/dL 
and a platelet count of 273,000/µL (Table 1). He had elevated 
aminotransferase levels less than two times upper normal 
limit. Electrolytes were normal. ESR was elevated up to 40 
mm/h. CRP was 3+ positive. Urinalysis was normal. Schisto-
somiasis was ruled out. Stool examination for ova/parasite 
for three consecutive times was negative. Serology tests for 
Fasciola,  visceral  larva  migrans  (Toxocara  canis),  and  hy-
datid disease (Ecchinococcus granolosus) was negative. An 
abdominal ultrasound was normal. CT of abdomen with in-
travenous and oral contrast showed multiple diffused 5–10-
mm lesions in both liver lobes. Esophagogastroduodenos-
copy  and  colonoscopy  were  normal.  Chest  radiography 
was normal. Bone marrow aspiration and biopsy showed 
a hypercellular marrow with polymorphic cell population 
and increased number of eosinophilic series. Liver biopsy 
was diffusely infiltrated by mixed inflammatory cells, pre-
dominantly clusters of eosinophils with liver parenchymal 
destruction in some areas. He received oral prednisolone 30 
mg daily which was tapered over six months and regained 
his lost weight. He is symptom-free now and eosinophilia 
has resolved. Also anemia was corrected by the treatment. 
A control CT of liver 12 months later, showed resolution of 
liver lesions.
Discussion
HES is most common in patients 20 to 50 years of age (4). 
The  FIP1L1-PDGFR  alpha-associated  variant  affects  mostly 
males, whereas other variants appear to affect males and fe-
males equally. Patients with HES may present with insidious 
and incidentally detected eosinophilia, gradually progres-
sive symptoms, or with life-threatening cardiac and neuro-
logic events such as thromoembolic stroke or encephalopa-
thy. The organ systems most commonly affected in HES are 
internal amorphous echogenic areas in addition to multiple 
ill-defined hypoechoic lesions in right liver lobe. Computed 
tomography (CT) confirmed a hyperdense mass (Figure 1). 
Esophagogastroduodenoscopy was normal. Chest radiogra-
phy was normal. Serologic markers for chronic viral hepati-
tis were negative and α-fetoprotein was normal. Ultrasound-
guided liver biopsy was done which revealed portal mixed 
neutrophilic and lymphocytic infiltrates, stellate (interface) 
hepatitis, and vague nodule formation but no eosinophilic 
infiltration.  Pathology  was  graded  as  “mild  to  moderate 
chronic  hepatitis”.  Bone  marrow  biopsy  showed  normo-
cellular polymorphic marrow with increased eosinophilic 
series. She was treated with oral prednisolone, 50 mg daily 
that was tapered over three months and remained asymp-
tomatic after six months; liver ultrasound and CT became 
normal and there was no more eosinophilia on peripheral 
blood film.
Case 2
The second patient was a 53-year-old Caucasian man with 
20 days history of fatigue, weakness, and steady right upper 
Table 1. Laboratory findings at presentation
Test results Patient 1 Patient 2
WBC (No/µL) 17870 16000
Polymorphonuclear (%) 19.6 21.4
Lymphocyte (%) 18.8 4.5
Eosinophil (%) 56.1 69
Basophil (%) 1.2 1
Monocyte (%) 2.6 3.3
Hemoglobin (mg/dL) 12.4 10.4
Platelet (No/µL) 433,000 273,000
ESR (mm/h) 65 40
CRP 3+ 3+
PT (s) 13 14
PTT (s) 28 46
ALT (U/L) 18 50
AST (U/L) 13 61
ALKP 163 463
Bilirubin T–D (mg/dL) 0.61–0.20 0.58–0.19Idiopathic hypereosinophilic syndrome and liver mass Shatery K et al. 125
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the heart, nervous system, skin, lungs, and gastrointestinal 
tract (5). Fatigue, cough, breathlessness, muscle pains, an-
gioedema, rash, fever, involvement of the heart, skin, nervous 
system, lungs, and spleen, each occurs in 40% to 64% of pa-
tients; liver, sinus, ocular, and gastrointestinal involvement 
are less common (14% to 32% each) (4, 6). Gastrointestinal 
manifestations include eosinophilic gastritis, enteritis, and/
or  colitis  causing  weight  loss,  abdominal  pain,  vomiting, 
and/or severe diarrhea (4). Hepatic involvement may take 
the form of chronic active hepatitis, focal hepatic lesions, eo-
sinophilic cholangitis, or the Budd-Chiari syndrome. History 
for allergic disorders, medications, and travelling should be 
sought and patients should be investigated for helminthic/
parasitic infections. Echocardiography and serum troponin 
level measurement should be done to monitor for cardiac 
involvement. Liver biopsy should be done in case of hepatic 
involvement to make a definite diagnosis and a bone mar-
row biopsy to rule out myeloproliferative disorders, masto-
cytosis, acute and chronic eosinophilic leukemia, etc. (7-11). 
These workups however, did not uncover end-organ involve-
ments in our patients except for liver damage. Both patients 
responded  well  to  glucocorticosteroid  therapy.  Both  pa-
tients are on low-dose steroid and monitored for symptoms 
and eosinophilia on follow-up visits. Presentation of HES as 
liver mass is rare; however, we reported two patients with-
out any other end-organ involvement. Our patients differed 
not only in gender and age but also in the pattern of liver 
involvement; the first patient had a hypodense mass in the 
right lobe while the second patient had multiple small dif-
fused lesions. Oh, et al. have previously reported a case with 
single liver mass (12). Lai, et al. also reported a 52-year-old 
woman presenting with recurrent abdominal pain and liver 
masses (13). In contrast to our second patient, the first one 
showed no eosinophilic infiltration in liver pathology. Simi-
lar observation has also been reported by Minola, et al. (14). 
Minola reported a 28-year-old woman, affected by idiopathic 
HES with bone marrow and pulmonary eosinophilic infil-
trates associated with peripheral eosinophilia and features 
of chronic hepatitis without a significant eosinophilic com-
ponent. This finding may support the hypothesis that liver 
damage in idiopathic HES may be due to circulating sub-
stances produced by eosinophils rather than direct infiltra-
tion of liver by them. Unfortunately, we did not perform IgE 
assay for our patients that is usually elevated in such cases.In 
conclusion, HES is a diagnosis that should be considered in 
liver masses accompanied by peripheral blood eosinophilia. 
Liver biopsy, bone marrow aspiration and biopsy, and helm-
intic and parasitologic laboratory tests are usually needed to 
establish the diagnosis. These patients usually respond very 
well to corticosteroid therapy. 
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